/ Print /

Pharmacy Best Practices

Despite hype, private payers slow to adopt oncology value-based modelsOncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
How health execs can partner with pharmacists to address opioidsDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
The top three pharmacy challenges of 2018Find out what challenges top the list, and what analysts say can be done about them.
Will biosimilars deliver on expectations?This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
Autoimmune drug pipeline highlightsMore targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Five changes healthcare executives can expect in 2018The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.
Four health programs successfully fight the opioid epidemicShocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch
Four PBM programs poised to rein in the opioid epidemicPBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
Unique clinic-pharmacy collaboration benefits hepatitis C patientsA Walgreens study sheds light on the benefits of patient-centered pharmacy-based programs.
How one project will change the way value is measured in healthcareThe Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.